Resultats de la cerca - Asmussen, Jon Thor
- Mostrar 1 - 6 resultats de 6
-
1
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis per Bjørnhart, Birgitte, Hansen, Karin Holmskov, Asmussen, Jon Thor, Jørgensen, Trine Lembrecht, Herrstedt, Jørn, Schytte, Tine
Publicat 2022Text -
2
-
3
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer per Naghavi-Behzad, Mohammad, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Braad, Poul-Erik, Asmussen, Jon Thor, Vogsen, Marianne, Kodahl, Annette Raskov, Gerke, Oke, Hildebrandt, Malene Grubbe
Publicat 2021Text -
4
FDG-PET/CT can rule out malignancy in patients with vocal cord palsy per Thomassen, Anders, Nielsen, Anne Lerberg, Lauridsen, Jeppe Kiilerich, Blomberg, Björn Alexander, Hess, Søren, Petersen, Henrik, Johansen, Allan, Asmussen, Jon Thor, Sørensen, Jesper Roed, Johansen, Jørgen, Godballe, Christian, Høilund-Carlsen, Poul Flemming
Publicat 2014Text -
5
Benefits and harms of implementing [(18)F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study per Vogsen, Marianne, Jensen, Jeanette Dupont, Gerke, Oke, Jylling, Anne Marie Bak, Asmussen, Jon Thor, Christensen, Ivar Yannick, Braad, Poul-Erik, Thye-Rønn, Peter, Søe, Katrine Lydolph, Ewertz, Marianne, Hildebrandt, Malene Grubbe
Publicat 2021Text -
6
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT per Naghavi-Behzad, Mohammad, Vogsen, Marianne, Vester, Rasmus Mølgård, Olsen, Maiken Madsen Bjerregaard, Oltmann, Hjalte, Braad, Poul-Erik, Asmussen, Jon Thor, Gerke, Oke, Vach, Werner, Kidholm, Kristian, Kodahl, Annette Raskov, Weber, Wolfgang, Hildebrandt, Malene Grubbe
Publicat 2022Text